Approbation of the Cancer Treatment Approach Based on the Eradication of TAMRA+ Cancer Stem Cells in a Model of Murine Cyclophosphamide Resistant Lymphosarcoma › Research Explorer

Novosibirsk State University's Research Portal

Approbation of the Cancer Treatment Approach Based on the Eradication of TAMRA+ Cancer Stem Cells in a Model of Murine Cyclophosphamide Resistant Lymphosarcoma

Research output: Contribution to journal › Article › peer-review

DOI

https://doi.org/10.21873/anticanres.14011
Final published version

Polina E. Kisaretova
Svetlana S. Kirikovich
Genrich S. Ritter
Yaroslav R. Efremov
Oleg S. Taranov
Tatyana D. Dubatolova
Anastasia S. Proskurina
Ekaterina A. Potter
Evgenia V. Dolgova
Sergey V. Sidorov
Aleksandr A. Ostanin
Elena R. Chernych
Sergey S. Bogachev

Original language	English
Pages (from-to)	795-805
Number of pages	11
Journal	Anticancer research
Volume	40
Issue number	2
DOIs	https://doi.org/10.21873/anticanres.14011
Publication status	Published - 1 Feb 2020

Research areas

cancer stem cells eradication, cyclophosphamide, double-stranded DNA, RLS lymphosarcoma, secondary ascites, Cyclophosphamide, Doublestranded DNA, Secondary ascites, Cancer stem cells eradication

OECD FOS+WOS

ID: 23427444